% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

  • technocrat676 technocrat676 Aug 15, 2013 12:48 PM Flag

    AMGN staring at downgrades

    In my opinion, if AMGN does not seal the deal with ONXX, it will be penalized for lack of leadership and conviction. I see downgrades coming for AMGN from analyst who see AMGN/ONXX as a great strategic fit. It is all about leadership and now is the time it is being tested.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Good Point.Look at Gilead. It paid 11 billion$ for Pharmacett--a high risk drug for Hepititus( Inhibitex and Identix trials stopped by FDA ,but Pharmacett drug going ok with no significant liver damage.). Gilead stock has done well.
      Amgen is in trouble with dismal growth over next 5 years. It needs to act like Gilead and buy Onyx.

173.53-1.27(-0.73%)Sep 26 4:00 PMEDT